Related Experiment Video

Updated: Dec 13, 2025

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.2K

Investigation of cancer drug resistance mechanisms by phosphoproteomics

Joelle C Boulos1, Muhammad Rahama Yousof Idres1, Thomas Efferth1

  • 1Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomolecular Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.

Pharmacological Research
|July 27, 2020
PubMed

Insights

Phosphoproteomics analyzes protein phosphorylation to reveal cancer drug responses. This method helps predict cancer treatment sensitivity or resistance, aiding in developing new therapies and diagnostics.

Area of Science:

  • Oncology
  • Biochemistry
  • Proteomics

Background:

  • Genomic and transcriptomic methods alone are insufficient for understanding cancer heterogeneity.
  • Protein expression and modification analyses are crucial for understanding functional impacts of mutations.
  • Protein kinases are key regulators of cellular functions and are implicated in cancer development and drug resistance.

Purpose of the Study:

  • To highlight the role of phosphoproteomics in cancer research.
  • To review phosphoproteomics' utility in predicting cancer therapy outcomes.
  • To explore phosphoproteomics for identifying diagnostic biomarkers.

Main Methods:

  • Review of current literature on phosphoproteomics in cancer.
  • Analysis of protein phosphorylation patterns.
  • Correlation of phosphoproteomic data with drug sensitivity and resistance.

Main Results:

  • Phosphoproteomics provides functional insights beyond genomic data.
  • This technique can predict cancer sensitivity or resistance to tyrosine kinase inhibitors and cytotoxic drugs.
  • Phosphoproteomics aids in identifying potential biomarkers for clinical diagnostics.

Conclusions:

  • Phosphoproteomics is an advanced tool for monitoring cancer therapies and discovering novel drugs.
  • Understanding protein phosphorylation is vital for overcoming cancer drug resistance.
  • Phosphoproteomics holds significant potential for personalized cancer treatment and diagnostics.
Keywords:
CancerChemotherapyDrug resistancePhosphorylationProteomics

More Related Videos

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer12:23

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on: August 2, 2018

12.6K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.8K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K